NCT07786883

Brief Summary

The goal of this experimental study is to test the effectiveness of Dialectic Behavioural Therapy in patients with Autism Spectrum Disorder. The aim questions are:

  • Follow DBT of 10 months
  • Keep a diary on their urge of maladaptive emotion regulation strategies and well-being

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
17mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

August 26, 2026

Status Verified

July 1, 2026

Enrollment Period

11 months

First QC Date

August 12, 2026

Last Update Submit

August 25, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Maladaptive Emotion Regulation Strategies (MERS) measured assessed by the DBT diary (Linehan, 2016)

    MERS is the average of the urge to six maladaptive emotion regulation strategies: 1. suicidal thoughts/behaviours 2. self-harm, 3. eating problems 4. substance abuse 5. anger outburst 6. other All emotion regulation strategies are measured on a scale from 0 - 100. MERS will be created by adding scores of the six strategies together and divide it by 6.

    From enrollment to end of treatment at 10 months

  • Emotional well-being as assessed by the DBT diary (Linehan, 2016)

    The daily diary measures emotional suffering and happiness on a scale from 0 - 100. Emotional suffering is inverted, following the logic that higher emotional suffering means lower emotional well-being. The variable well-being is created by averaging the invert of emotional suffering and happiness.

    From enrollment to end of treatment at 10 months

Secondary Outcomes (3)

  • Social behaviour

    At start of baseline (T1), at end of treatment phase at 10 months (T2)

  • Emotion regulation

    At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)

  • Generic psychopathology and functioning

    At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)

Study Arms (1)

Dialectic Behavioural Therapy

EXPERIMENTAL

Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder, given for 10 months

Behavioral: Dialectic Behavioural Therapy

Interventions

Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder

Dialectic Behavioural Therapy

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-5 diagnosis of ASD
  • Sufficient understanding, as demonstrated in conversation with intake therapist;
  • Explicit behavioural problems, which, according to patient and therapist, lead to functional problems (like suicidal ideation, auto mutilation, emotional outburst and interpersonal conflicts);
  • BMI \> 17;
  • Commitment to the therapy and shared goals as assessed by intake therapist;

You may not qualify if:

  • Antisocial behaviour which interrupts the group climate;
  • Presence of a trauma-related disorder that is likely to interfere with the ability to engage effectively in DBT or that requires specialized trauma-focused treatment prior to or alongside DBT as assessed by intake team;
  • Excessive dependency on substances for which no parallel appropriate policy can be made;
  • Diagnosis of psychotic disorder if not stable;
  • Diagnosed with bipolar disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GGZ Friesland

Leeuwarden, Provincie Friesland, 8934AD, Netherlands

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study will be a Single Case Experimental Design (SCED). Therefore each case functions as their own control. Daily diary data will be analysed, just like secondary questionnaire outcomes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2026

First Posted

August 26, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

August 26, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

To protect the participants of the study

Locations